PROGNOSTIC SIGNIFICANCE OF NON-SPECIFIC SYSTEMIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE

Authors:

Abstract:

To evaluate the prognostic significance of markers of nonspecific systemic inflammation as predictors of unfavorable prognosis in patients with coronary heart disease, data from 135 patients with uncomplicated disease and 27 with unfavorable outcomes were analyzed. A 2-year prospective study showed that unfavorable cardiovascular events were significantly more common in patients with coronary heart disease and elevated levels of biomarkers of nonspecific systemic inflammation compared with those with lower values. The presence of myocardial infarction at baseline, a decrease in left ventricular ejection fraction <50 %, and increased levels of markers of nonspecific systemic inflammation such as C-reactive protein, determined by a highly sensitive method, and tumor necrosis factor-α had significant predictive value for the likelihood of unfavorable events.

Keywords:

coronary heart disease patient prognosis nonspecific systemic inflammation high-sensitivity C-reactive protein tumor necrosis factor-α fibrinogen blood lipids atherosclerosis

References:

1. Kovalenko VM, Kornatskyy VM, editors. Aktualni problemy zdorovya ta minimizatsiya yikh v umovakh zbroynoho konfliktu v Ukrayini: posibnyk. Kyyiv: Derzhavna ustanova «Natsionalnyy naukovyy tsentr «Instytut kardiolohiyi imeni akademika M.D.Strazheska»; 2018. [in Ukrainian]
2. ESC guidelines on the management of stable coronary artery disease. European Heart Journal. 2013;34(38):2949–3003. doi:10.1093/eurheartj/eht296
3. Braunwald E. Creating controversy where none exists: The important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. European Heart Journal. 2011 Sept 6;33(4):430–2. doi:10.1093/eurheartj/ehr310
4. Cacko A, Kondracka A, Gawałko M, Główczyńska R, Filipiak KJ, Bartoszewicz Z, et al. Novel biochemical predictors of unfavorable prognosis for stable coronary disease. Medicine. 2018;97(37). doi: 10.1097/md.0000000000012372
5. Crea F, Libby P. Acute coronary syndromes. Circulation. 2017;136(12):1155–66. doi: 10.1161/CIRCULATIONAHA.117.029870
6. Cui Z, Zhao G, Liu X. Blood fibrinogen level as a biomarker of adverse outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Medicine. 2022;101(33). doi: 10.1097/md.0000000000030117
7. De Caterina R, D’Ugo E, Libby P. Inflammation and thrombosis – testing the hypothesis with anti-inflammatory drug trials. Thrombosis and Haemostasis. 2016;116(12):1012–21. doi: 10.1160/th16-03-0246
8. Hou Y, Carrim N, Wang Y, Gallant RC, Marshall A, Ni H. Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin mediated protein wave of hemostasis. The Journal of Biomedical Research. 2015;29(6):437–44. doi:10.7555/jbr.29.20150121
9. Lindstrom M, DeCleene N, Dorsey H, et al. Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021. J Am Coll Cardiol. 2022 Dec, 80 (25) 2372–2425
10. Ridker PM. Residual inflammatory risk: Addressing the obverse side of the Atherosclerosis Prevention Coin. European Heart Journal. 2016 Feb 22;37(22):1720–2. doi:10.1093/eurheartj/ehw024
11. Romanova VO, Kuzminova NV, Romanova LO, Lozinsky SE, Knyazkova II, Kulchytska OM, et al. Indicators of nonspecific systemic inflammation as criteria for destabilization of the course of coronary artery disease. World of Medicine and Biology. 2022;18(82):153. doi:10.26724/2079-8334-2022-4-82-153-157
12. Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, et al. Epidemiology of Cardiovascular Disease in Europe. Nature Reviews Cardiology. 2021;19(2):133-43. doi: 10.1038/s41569-021-00607-3
13. Urschel K, Cicha I. TNF-Α in the cardiovascular system: From physiology to therapy. International Journal of Interferon, Cytokine and Mediator Research. 2015; 7:9–25. doi: 10.2147/ijicmr.s64894
14. Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circulation Research. 2019;124(2):315–27. doi: 10.1161/circresaha.118.313591a

Publication:

«World of Medicine and Biology» Vol. 20 No. 88 (2024) , с. 129-133
УДК 616.13-002:616.12-005.4-08

DOI:

https://doi.org/10.26724/2079-8334-2024-2-88-129-133